RCA
CVS icon

Resonant Capital Advisors’s CVS Health CVS Stock Holding History

Resonant Capital Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$645K Buy
6,237
+1,105
+22% +$98.6K 0.03% 246
2026
Q1 		$369K Buy
5,132
+824
+19% +$63.5K 0.02% 335
2025
Q4 		$342K Buy
4,308
+75
+2% +$5.91K 0.02% 314
2025
Q3 		$319K Buy
4,233
+158
+4% +$10.8K 0.02% 320
2025
Q2 		$281K Buy
4,075
+1,017
+33% +$66.7K 0.02% 341
2025
Q1 		$207K Buy
+3,058
New +$183K 0.01% 358
2024
Q4 		– Sell
-31,884
Closed -$2M – 350
2024
Q3 		$2M Sell
31,884
-10,680
-25% -$623K 0.15% 108
2024
Q2 		$2.51M Buy
42,564
+1,018
+2% +$63.7K 0.2% 89
2024
Q1 		$3.31M Buy
41,546
+385
+0.9% +$29.4K 0.28% 75
2023
Q4 		$3.25M Sell
41,161
-1,162
-3% -$82.7K 0.31% 68
2023
Q3 		$2.95M Sell
42,323
-401
-0.9% -$28.4K 0.32% 72
2023
Q2 		$2.95M Sell
42,724
-659
-2% -$46.9K 0.32% 73
2023
Q1 		$3.22M Sell
43,383
-326
-0.7% -$27.3K 0.37% 67
2022
Q4 		$4.07M Buy
43,709
+749
+2% +$72.3K 0.51% 53
2022
Q3 		$4.1M Buy
42,960
+379
+0.9% +$37.5K 0.62% 43
2022
Q2 		$3.95M Sell
42,581
-1,258
-3% -$123K 0.62% 49
2022
Q1 		$4.43M Buy
43,839
+761
+2% +$79.9K 0.66% 35
2021
Q4 		$4.44M Buy
43,078
+3,213
+8% +$297K 0.67% 33
2021
Q3 		$3.38M Buy
39,865
+5,019
+14% +$420K 0.59% 34
2021
Q2 		$2.91M Buy
34,846
+412
+1% +$33.7K 0.56% 33
2021
Q1 		$2.59M Buy
34,434
+3,496
+11% +$255K 0.53% 33
2020
Q4 		$2.11M Buy
30,938
+7,255
+31% +$472K 0.5% 41
2020
Q3 		$1.38M Buy
23,683
+3,202
+16% +$199K 0.39% 57
2020
Q2 		$1.33M Sell
20,481
-8,871
-30% -$559K 0.39% 56
2020
Q1 		$1.74M Buy
29,352
+3,406
+13% +$227K 0.63% 47
2019
Q4 		$1.93M Buy
+25,946
New +$1.82M 0.61% 48

Other funds holding CVS

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Resonant Capital Advisors's CVS Position: Q2 2026 in Review

Resonant Capital Advisors increased its CVS Health (CVS) stake by 22% in Q2 2026, buying an estimated $98.6K and bringing the position to 6,237 shares worth $645K. The position accounts for 0.03% of the portfolio, ranked #246.

Resonant Capital Advisors first reported a position in CVS in Q4 2019 and has held it in 26 quarters since. The position peaked at $4.44M in Q4 2021. 937 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Resonant Capital Advisors held 6,237 shares of CVS Health worth $645K as of Q2 2026.
  • Resonant Capital Advisors bought 1,105 CVS Health shares in Q2 2026, an estimated $98.6K.
  • CVS Health made up 0.03% of Resonant Capital Advisors's portfolio in Q2 2026, its #246 holding.
  • Resonant Capital Advisors first reported a position in CVS Health in Q4 2019 and has held it in 26 quarters since.
  • Resonant Capital Advisors's CVS Health position peaked at $4.44M in Q4 2021.
  • 937 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Resonant Capital Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.